Published in J Mol Signal on July 05, 2007
Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism. Cytokine Growth Factor Rev (2009) 1.39
Applications of small molecule BMP inhibitors in physiology and disease. Cytokine Growth Factor Rev (2009) 1.35
BMP signaling in vascular development and disease. Cytokine Growth Factor Rev (2010) 1.26
The RGM/DRAGON family of BMP co-receptors. Cytokine Growth Factor Rev (2009) 1.21
Neogenin interacts with hemojuvelin through its two membrane-proximal fibronectin type III domains. Biochemistry (2008) 1.20
Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression. J Biol Chem (2010) 0.96
Repulsive guidance molecule (RGM) family proteins exhibit differential binding kinetics for bone morphogenetic proteins (BMPs). PLoS One (2012) 0.91
BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells. J Biol Chem (2009) 0.86
Roles of BMP signaling pathway in lip and palate development. Front Oral Biol (2012) 0.86
Novel roles of the chemorepellent axon guidance molecule RGMa in cell migration and adhesion. Mol Cell Biol (2012) 0.82
Repulsive guidance molecules (RGMs) and neogenin in bone morphogenetic protein (BMP) signaling. Mol Reprod Dev (2013) 0.82
Bone morphogenetic protein signaling in musculoskeletal cancer. J Cancer Res Clin Oncol (2016) 0.82
Proteomic analysis and molecular modelling characterize the iron-regulatory protein haemojuvelin/repulsive guidance molecule c. Biochem J (2013) 0.81
Anti-Müllerian hormone recruits BMPR-IA in immature granulosa cells. PLoS One (2013) 0.78
Spatiotemporal expression of repulsive guidance molecules (RGMs) and their receptor neogenin in the mouse brain. PLoS One (2013) 0.78
Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells. Oncotarget (2016) 0.78
Liver and muscle hemojuvelin are differently glycosylated. BMC Biochem (2011) 0.78
Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth. Oncotarget (2015) 0.75
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
TGF-beta signal transduction. Annu Rev Biochem (1998) 17.83
TGFbeta signaling in growth control, cancer, and heritable disorders. Cell (2000) 12.38
The transforming growth factor-beta family. Annu Rev Cell Biol (1990) 10.62
Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J (1998) 10.01
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet (2006) 8.32
Controlling TGF-beta signaling. Genes Dev (2000) 8.13
Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol (1994) 5.93
Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem (2001) 5.89
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet (2003) 5.82
Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell (1983) 5.71
Signal transduction by the TGF-beta superfamily. Science (2002) 5.61
Improving biosensor analysis. J Mol Recognit (2000) 4.83
Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev (2003) 3.85
Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem (1992) 3.57
Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A (1990) 3.52
Betaglycan presents ligand to the TGF beta signaling receptor. Cell (1993) 3.48
Bone morphogenetic proteins in development. Curr Opin Genet Dev (1996) 3.37
Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature (1999) 3.16
Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol (1998) 3.00
Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem (1999) 2.77
Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science (1999) 2.72
TGF-beta receptor function in the endothelium. Cardiovasc Res (2005) 2.68
Advances in surface plasmon resonance biosensor analysis. Curr Opin Biotechnol (2000) 2.18
Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem (2005) 2.07
DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem (2005) 1.89
RGM is a repulsive guidance molecule for retinal axons. Nature (2002) 1.82
Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. Mol Cell Biol (2002) 1.80
Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology (1992) 1.75
Repulsive guidance molecule (RGM) gene function is required for neural tube closure but not retinal topography in the mouse visual system. J Neurosci (2004) 1.71
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood (2004) 1.59
Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol Chem (2004) 1.47
Transforming growth factor-beta (TGF-beta). Int J Biochem Cell Biol (1998) 1.43
Global analysis of a macromolecular interaction measured on BIAcore. Biochem Biophys Res Commun (1996) 1.42
EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1. Genes Dev (2003) 1.37
Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci U S A (2003) 1.35
Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses. J Biol Chem (2005) 1.28
Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood (2004) 1.20
Hepatic and extrahepatic expression of the new iron regulatory protein hemojuvelin. Haematologica (2004) 1.05
Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis. Endocrinology (2005) 0.93
Cripto, a multifunctional partner in signaling: molecular forms and activities. Sci STKE (2002) 0.82
Crowding delays treatment and lengthens emergency department length of stay, even among high-acuity patients. Ann Emerg Med (2009) 3.07
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol (2008) 2.95
BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem (2003) 2.01
BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun (2003) 1.97
The effect of triage diagnostic standing orders on emergency department treatment time. Ann Emerg Med (2010) 1.57
Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem (2005) 1.56
Health care utilization and needs after pediatric traumatic brain injury. Pediatrics (2006) 1.56
Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp Cell Res (2002) 1.55
The emergency department occupancy rate: a simple measure of emergency department crowding? Ann Emerg Med (2007) 1.42
Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev (2005) 1.42
Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem (2004) 1.34
The Pediatric Quality of Life Inventory: an evaluation of its reliability and validity for children with traumatic brain injury. Arch Phys Med Rehabil (2005) 1.33
Health-related quality of life during the first year after traumatic brain injury. Arch Pediatr Adolesc Med (2006) 1.32
Family burden after traumatic brain injury in children. Pediatrics (2009) 1.29
A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am (2003) 1.21
Does providing prescription information or services improve medication adherence among patients discharged from the emergency department? A randomized controlled trial. Ann Emerg Med (2013) 1.15
rhBMP-12 accelerates healing of rotator cuff repairs in a sheep model. J Bone Joint Surg Am (2008) 1.09
The challenge of predicting demand for emergency department services. Acad Emerg Med (2008) 1.04
Executive functioning in the first year after pediatric traumatic brain injury. Pediatrics (2008) 1.04
Comparison of methods for measuring crowding and its effects on length of stay in the emergency department. Acad Emerg Med (2011) 1.03
Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model. J Bone Joint Surg Am (2004) 0.98
Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J Clin Periodontol (2007) 0.97
Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations. J Clin Periodontol (2008) 0.97
rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model. J Bone Joint Surg Am (2010) 0.96
rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg Am (2006) 0.96
Comparing National Institutes of Health funding of emergency medicine to four medical specialties. Acad Emerg Med (2011) 0.95
Periodontal repair in dogs: effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol (2004) 0.95
Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol (2002) 0.92
rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J Bone Joint Surg Am (2006) 0.92
Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs. J Clin Periodontol (2008) 0.90
Protection against anoikis and down-regulation of cadherin expression by a regulatable beta-catenin protein. J Biol Chem (2002) 0.89
Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration. J Periodontol (2002) 0.89
Bone consolidation is enhanced by rhBMP-2 in a rabbit model of distraction osteogenesis. J Orthop Res (2002) 0.89
Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates. J Clin Periodontol (2008) 0.89
Periodontal repair in dogs: evaluation of a bioabsorbable space-providing macroporous membrane with recombinant human bone morphogenetic protein-2. J Periodontol (2003) 0.88
Ultrasound-guided peripheral intravenous access program is associated with a marked reduction in central venous catheter use in noncritically ill emergency department patients. Ann Emerg Med (2012) 0.87
rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res (2004) 0.87
Periodontal repair in dogs: evaluation of a bioresorbable calcium phosphate cement (Ceredex) as a carrier for rhBMP-2. J Clin Periodontol (2004) 0.87
Emergency department physician-level and hospital-level variation in admission rates. Ann Emerg Med (2013) 0.86
Peri-implant bone regeneration using recombinant human bone morphogenetic protein-2 in a canine model: a dose-response study. J Periodontal Res (2002) 0.86
A randomized controlled trial of the effect of service delivery information on patient satisfaction in an emergency department fast track. Acad Emerg Med (2011) 0.85
Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects. Clin Oral Implants Res (2007) 0.84
Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs. J Periodontol (2010) 0.84
Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier. Clin Implant Dent Relat Res (2003) 0.84
Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon. J Periodontol (2002) 0.83
Characterization of primary human skeletal muscle cells from multiple commercial sources. In Vitro Cell Dev Biol Anim (2013) 0.83
RhBMP-2/alphaBSM induces significant vertical alveolar ridge augmentation and dental implant osseointegration. Clin Implant Dent Relat Res (2002) 0.81
Impact of Subsidized Health Insurance Coverage on Emergency Department Utilization by Low-income Adults in Massachusetts. Med Care (2015) 0.81
Successful sonographic visualisation of the abdominal aorta differs significantly among a diverse group of credentialed emergency department providers. Emerg Med J (2010) 0.81
Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res (2003) 0.80
Creation of surge capacity by early discharge of hospitalized patients at low risk for untoward events. Disaster Med Public Health Prep (2009) 0.80
Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs. J Clin Periodontol (2010) 0.80
Synthetic thermoreversible polymers are compatible with osteoinductive activity of recombinant human bone morphogenetic protein 2. Tissue Eng (2002) 0.79
Characterization of a calcium phosphate-based matrix for rhBMP-2. Methods Mol Biol (2004) 0.79
Mycobacterium leprae upregulates IRGM expression in monocytes and monocyte-derived macrophages. Inflammation (2014) 0.79
Observations on healing following endodontic surgery in nonhuman primates (Macaca fascicularis): effects of rhBMP-2. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.78
Effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of periodontal attachment following tooth replantation in dogs. J Clin Periodontol (2004) 0.78
Engineering what comes naturally. Nat Biotechnol (2003) 0.77
rhBMP-2/calcium phosphate matrix induces bone formation while limiting transient bone resorption in a nonhuman primate core defect model. J Bone Joint Surg Am (2012) 0.77
Relation of urotensin II levels to lone atrial fibrillation. Am J Cardiol (2009) 0.77
Provider variation in fast track treatment time. Med Care (2012) 0.76
Oxidized high-density lipoprotein impairs endothelial progenitor cells' function by activation of CD36-MAPK-TSP-1 pathways. Antioxid Redox Signal (2014) 0.76
Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. J Periodontol (2005) 0.76
Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys. J Periodontol (2003) 0.76
Intraosseous injection of rhBMP-2/calcium phosphate matrix improves bone structure and strength in the proximal aspect of the femur in chronic ovariectomized nonhuman primates. J Bone Joint Surg Am (2013) 0.76
Factors Influencing Time-Dependent Quality Indicators for Patients With Suspected Acute Coronary Syndrome. J Patient Saf (2016) 0.75
Synthesis of isoflavones by room-temperature nickel-catalyzed cross-couplings of 3-iodo(bromo)chromones with arylzincs. Mol Divers (2014) 0.75
Emergency physicians accurately interpret video capsule endoscopy findings in suspected upper gastrointestinal hemorrhage: a video survey. Acad Emerg Med (2013) 0.75
Reduced T-Cell Thymic Export Reflected by sj-TREC in Patients with Coronary Artery Disease. J Atheroscler Thromb (2016) 0.75
Routine screening for asymptomatic abdominal aortic aneurysm in high-risk patients is not recommended in emergency departments that are frequently crowded. Acad Emerg Med (2009) 0.75
Comparison of the time to onset of action on myocardial ischaemia following intravenous administration of isosorbide dinitrate and 5-isosorbide mononitrate in Chinese patients. Arzneimittelforschung (2004) 0.75
Surface-etching enhances titanium implant osseointegration in newly formed (rhBMP-2-induced) and native bone. Int J Oral Maxillofac Implants (2007) 0.75